BioMarin Pharmaceutical
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
公司地址 770 Lindaro Street, San Rafael, CA, USA, 94901
電話號碼 +1 415 506-6700
傳真號碼 +1 415 382-7889
公司網頁 https://www.biomarin.com
員工數量 3221
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Cristin Hubbard Executive Vice President and Chief Commercial Officer 美元 662.31K 21/04/2026
Ms. Rashmi Virendra Ramchandani Vice President and Chief Accounting Officer -- 21/04/2026
Mr. Alexander Hardy Director, President and Chief Executive Officer 美元 1.13M 21/04/2026
Mr. G. Eric Davis Executive Vice President, Chief Legal Officer and Secretary -- 21/04/2026
Mr. Brian R. Mueller Executive Vice President and Chief Financial Officer 美元 721.15K 21/04/2026
Dr. Charles Greg Guyer, PhD Chief Technical Officer and Executive Vice President 美元 697.12K 21/04/2026
Dr. Gregory R. Friberg, M.D. Executive Vice President and Chief Research and Development Officer 美元 705.65K 21/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Richard A. Meier Chairman of the Board 21/04/2026
Dr. Willard H. Dere, M.D. Independent Director 21/04/2026
Mr. Alexander Hardy Director, President and Chief Executive Officer 21/04/2026
Mr. Robert J. Hombach Independent Director 21/04/2026
Dr. Maykin Ho, PhD Independent Director 21/04/2026
Mr. Ian T. Clark Independent Director 21/04/2026
Ms. Elizabeth McKee Anderson, M.B.A. Independent Director 21/04/2026
Mr. Timothy P. Walbert Independent Director 21/04/2026
Ms. Barbara W. Bodem Independent Director 21/04/2026
Mr. Mark Joseph Enyedy Independent Director 21/04/2026
Dr. Athena Countouriotis, M.D. Independent Director 21/04/2026
 
所屬ETF (更新日期: 02/05/2026 04:43)
代號 名稱 佔比% ▼ 持有日期
IWPiShares Russell Mid-Cap Growth ETF<0.000001%06/03/2026
JSTCAdasina Social Justice All Cp Glbl ETF<0.000001%03/03/2026
KOKUXtrackers MSCI Kokusai Equity ETF<0.000001%25/11/2025
LRGEClearBridge Large Cap Growth Select ETF<0.000001%06/03/2026
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF<0.000001%25/11/2025
ONOFGlobal X Adaptive US Risk Management ETF<0.000001%07/08/2025
PABUiShares Paris-Algnd Clmt Optd MSCIUSAETF<0.000001%04/03/2026
PAMCPacer Lunt MidCap Multi-Factor Alt ETF<0.000001%04/09/2025
PBUSInvesco MSCI USA ETF<0.000001%25/11/2025
PEPSParametric Equity Plus ETF<0.000001%07/08/2025
PFUTPutnam Sustainable Future ETF<0.000001%30/09/2025
PWSPacer WealthShield ETF<0.000001%13/03/2026
QQQJInvesco NASDAQ Next Gen 100 ETF<0.000001%22/12/2025
QUSStt Strt® SPDR® MSCI USA StratFacs ETF<0.000001%25/11/2025
QVALAlpha Architect US Quantitative Val ETF<0.000001%30/10/2025
QWLDState Street® SPDR® MSCI Wld StrtFcs ETF<0.000001%25/11/2025
RALSProShares RAFI® Long/Short<0.000001%30/04/2022
RCGERockCreek Global Equality ETF<0.000001%26/09/2025
SCHGSchwab US Large-Cap Growth ETF™<0.000001%23/09/2025
SDGiShares MSCI Global Sust Dev Goals ETF<0.000001%06/03/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.